Skip to main content
URGN logo

URGN · UroGen Pharma Ltd. · Proposed Sales

Track URGN — free
$40.63 +0.18 (+0.44%) At close · Sep 30
Market Cap
$2.02B
Shares
48.88M
Volume · Sep 30 641.38K Avg daily vol (3M) 837.83K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-09-09 Mark Schoenberg 871
2026-09-09 Jason Smith 1,519
2026-08-20 Schoenberg Mark 60,677
2026-07-09 Schoenberg Mark 10,000
2026-06-22 Schoenberg Mark 10,000
2026-06-09 Schoenberg Mark 5,222
2026-05-08 Schoenberg Mark 10,000
2026-02-03 Schoenberg Mark 13,333
2025-11-19 Schoenberg Mark 10,000
2025-09-09 Schoenberg Mark 871
2025-09-09 Smith Jason Drew 1,520
2025-07-29 Schoenberg Mark 5,149
2025-07-29 Smith Jason Drew 7,522
2025-06-10 Schoenberg Mark 5,162
2024-09-10 Schoenberg Mark 859
2024-06-11 Schoenberg Mark 5,153
2024-03-18 Schoenberg Mark 12,000
2024-02-01 Schoenberg Mark 3,789
2024-02-01 Smith Jason Drew 4,993
Showing 1–19 of 19 filings
Key facts CIK 1668243 CUSIP M96088105 13F (30d) 6 filings 6 filers Visit website Investor relations